CovarsaDx to Highlight Integrated Clinical Trial Expertise at ADLM 2025
CovarsaDx, a leading medical device and diagnostics clinical research organization (CRO) and advisory firm will exhibit at the 2025 Association for Diagnostics & Laboratory Medicine Conference (ADLM) Annual Scientific Meeting & Clinical Lab Expo at McCormick Place Convention Center in Chicago July 27-31.
Attendees are invited to visit CovarsaDx at Booth #4334 to explore how its integrated clinical, regulatory, and quality services help sponsors take their diagnostic innovations from development through commercializationby integrating efficiency, accuracy and quality.
In addition to human health expertise, CovarsaDx will also feature at the booth its animal health CRO, ZoaDx. ZoaDx supports veterinary diagnostics, therapeutics, and vaccine studies, providing sponsors with a trusted partner for animal health clinical research. Sponsors interested in exploring cross-species diagnostic platforms or expanding into the animal health space will also benefit from conversations with the ZoaDx leadership team.
“As the regulatory and clinical landscapes continue to evolve, clients need partners who understand the full picture across sectors and study types,” said Chermaen Lindberg, President & CEO of CovarsaDx. “Whether you’re developing a De Novo diagnostic or advancing a veterinary therapeutic, our team is ready to support you with an integrated, hands-on approach.”
Visitors to Booth #4334 can learn how CovarsaDx helps sponsors:
- Design efficient studies from day one – Protocols are built to balance scientific integrity with real-world practicality, from early feasibility to commercialization.
- Accelerate trial timelines – Tailored site selection and flexible startup strategies help get studies off the ground faster.
- Comprehensive regulatory services – Talented and experienced regulatory experts with a proven track record worldwide.
- Standardize trial execution and documentation – Quality-focused processes reduce risk and strengthen data integrity across studies.
- Benefit from cross-functional collaboration – Clinical, regulatory, and quality experts work as an integrated team with no silos, no gaps.
The ADLM Clinical Lab Expo is the premier gathering for global laboratory medicine, bringing together clinical lab professionals, exhibitors, and leaders in the laboratory medicine sector, including those in veterinary medicine. ADLM 2025 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo) is a program of the Association for Diagnostics & Laboratory Medicine and is held this year in partnership with the Canadian Society for Clinical Chemistry (CSCC). Discover how the CovarsaDx team, through proven expertise and strategic partnerships, is partnering with our clients to enable innovative technologies and improve patient access.
Leadership from both CovarsaDx and ZoaDx will be available throughout the event to discuss strategic opportunities and answer sponsor questions. Team members include:
- Chermaen Lindberg – President and CEO, CovarsaDx; Senior Advisor, ZoaDx
- Marielle Lejcher – Sr. Director, Regulatory Affairs and Quality; President, ZoaDx
- Rich Masino – Sr. Director, Strategic Partnerships and Business Development
- Additional clinical and site operations experts
ADLM 2025 attendees are encouraged to schedule time with the CovarsaDx team for a tailored discussion of services by contacting rich.masino@covarsadx.com.
For more information on CovarsaDx’s activities at ADLM, visit the company website or visit the conference booth (#4434) to experience the full breadth of CovarsaDx’s capabilities. For live updates during the event, follow CovarsaDx on LinkedIn.
About CovarsaDx
CovarsaDx is a prominent Clinical Research Organization (CRO) specializing in the areas of in-vitro diagnostics (IVDs) and medical devices. The company provides agile responses to patient population needs and evolving regulatory requirements to enable faster pathways to market. Our team brings extensive industry experience across regulatory, quality, and clinical operations—including regulatory strategists, quality specialists, study managers, monitors, data managers, and statisticians—working in sync to generate the robust evidence needed to advance life-saving technologies.
Through our affiliation with ClearDx Labs, a trusted clinical and analytical laboratory partner, we offer integrated capabilities for diagnostic assay testing and validation. This collaboration strengthens our ability to deliver high-quality data to support regulatory submissions and successful product entry into the market.
About ZoaDx
ZoaDx supports animal health and agricultural sustainability by offering precise, expert-driven clinical research and regulatory solutions. Through collaborative partnerships and innovative strategies, ZoaDx empowers clients to accelerate their path to market and achieve impactful results.